Anne Soikkeli
Papers
1
Total Citations
10
H-Index
1
About
Dr. Anne Soikkeli is a biomedical researcher whose work centers on the automation and optimization of cellular drug screening assays, with a particular focus on enhancing the efficiency and reproducibility of preclinical pharmaceutical testing. Her most cited study, "Feasibility Evaluation of 3 Automated Cellular Drug Screening Assays on a Robotic Workstation" (2009, 10 citations), represents a significant contribution to the field of high-throughput screening. In this work, Dr. Soikkeli successfully implemented and optimized three distinct cell-based assays on a TECAN Genesis robotic platform: the Caspase-Glo® 3/7 apoptosis assay, the sulforhodamine B (SRB) cytotoxicity assay, and the mechanistic Caco-2 permeability protocol. By systematically evaluating the feasibility of automating these critical assays, she provided a practical framework for laboratories seeking to transition from manual to automated workflows, thereby reducing variability and increasing throughput. Her research has helped bridge the gap between assay development and industrial-scale drug discovery, making her a valuable contributor to the advancement of automated cellular screening technologies.
Research Focus
Key Achievements
Top Papers
- 1